RNA interference
/ AR-en-AY in-ter-FEER-ents /
Imagine a busy mailroom where, to stop a particular message from being acted on, a guard simply intercepts and shreds every envelope that matches a known address. RNA interference is the cell's version of this targeted shredding. It is a system that uses small pieces of RNA to find and silence matching messenger RNAs — the working copies of genes — so the protein those messages encode never gets made, or gets made far less.
Precisely, RNA interference is a gene-silencing process triggered by short double-stranded RNA. The cell chops such RNA into tiny fragments (around 21-23 letters long), and one strand is loaded into a protein complex called RISC. This guide strand lets RISC scan the cell's messenger RNAs and recognize any whose sequence matches; the complex then cuts that messenger RNA or blocks its translation, shutting the gene's output down. Because the matching is by base-pairing, RNAi is exquisitely specific — it acts only on messages that read like its guide.
RNA interference matters in two big ways. In nature it is a defense and regulatory system: it silences viruses and roaming genetic parasites and helps fine-tune normal gene activity (closely related to microRNA control). In the lab and clinic it is a revolutionary tool: scientists can switch off almost any chosen gene by feeding in matching small RNA, which lets them probe gene function, and a small but growing number of approved drugs use this principle to silence disease-causing genes. The discovery earned a 2006 Nobel Prize.
An approved RNAi drug silences a gene in the liver that drives a rare nerve disease: a small synthetic RNA homes in on that gene's messenger RNA and has it destroyed, so the harmful protein is no longer produced.
RNAi as medicine: silence the gene behind a disease.
RNAi turns genes down by attacking their RNA after it's made — it does not edit or delete the DNA, so its silencing is reversible and dose-dependent, unlike a permanent gene knockout.